ArticleTranslational lung cancer research2025

The effect of durvalumab consolidation after definitive radiochemotherapy for non-operable stage III non-small cell lung cancer on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis.

Andreas Herz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.